Imidlertid blev HBV- DNA - responset ikke opretholdt efter behandlingen, da der hos alle patienter var en forværring af HBV- DNA efter seponering af adefovirdipivoxil og pegyleret interferon- alfa- 2a.
However, on-treatment HBV DNA response was not maintained off-therapy since all the patients had a rebound in HBV DNA after adefovir dipivoxil and pegylated interferon alpha-2a discontinuation.